Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid Desaturases | 8 | 2021 | 51 | 1.090 |
Why?
|
| Phospholipases A | 14 | 2005 | 31 | 0.940 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2021 | 68 | 0.810 |
Why?
|
| Neutrophils | 16 | 2016 | 120 | 0.780 |
Why?
|
| Pulmonary Surfactants | 6 | 2012 | 17 | 0.750 |
Why?
|
| Blood-Brain Barrier | 4 | 2025 | 52 | 0.750 |
Why?
|
| Asthma | 7 | 2021 | 261 | 0.720 |
Why?
|
| Arachidonic Acid | 10 | 2015 | 40 | 0.660 |
Why?
|
| Linoleic Acid | 4 | 2023 | 19 | 0.600 |
Why?
|
| Inflammation | 8 | 2020 | 506 | 0.590 |
Why?
|
| Eosinophils | 5 | 2009 | 32 | 0.570 |
Why?
|
| Phosphatidylglycerols | 4 | 2012 | 8 | 0.570 |
Why?
|
| Multigene Family | 4 | 2021 | 50 | 0.560 |
Why?
|
| Dietary Supplements | 2 | 2017 | 188 | 0.540 |
Why?
|
| Phospholipids | 3 | 2021 | 33 | 0.520 |
Why?
|
| Plant Oils | 3 | 2020 | 17 | 0.500 |
Why?
|
| Respiratory Distress Syndrome, Adult | 4 | 2015 | 50 | 0.490 |
Why?
|
| Fatty Acids, Omega-6 | 5 | 2017 | 36 | 0.450 |
Why?
|
| Phospholipases A2, Secretory | 2 | 2024 | 3 | 0.420 |
Why?
|
| Gold | 2 | 2024 | 19 | 0.370 |
Why?
|
| Metal Nanoparticles | 2 | 2024 | 16 | 0.370 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2011 | 1 | 0.360 |
Why?
|
| Group IA Phospholipases A2 | 1 | 2011 | 1 | 0.360 |
Why?
|
| Group IB Phospholipases A2 | 1 | 2011 | 1 | 0.360 |
Why?
|
| Organoids | 2 | 2024 | 99 | 0.340 |
Why?
|
| Dietary Fats | 2 | 2009 | 99 | 0.340 |
Why?
|
| Humans | 48 | 2025 | 32282 | 0.330 |
Why?
|
| gamma-Linolenic Acid | 3 | 2020 | 11 | 0.300 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2020 | 43 | 0.290 |
Why?
|
| Hydrolysis | 6 | 2021 | 41 | 0.290 |
Why?
|
| Models, Biological | 2 | 2020 | 408 | 0.270 |
Why?
|
| Genetic Variation | 2 | 2021 | 248 | 0.270 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 61 | 0.260 |
Why?
|
| Bronchoalveolar Lavage Fluid | 5 | 2012 | 59 | 0.250 |
Why?
|
| Diet | 3 | 2023 | 383 | 0.240 |
Why?
|
| Immune System | 1 | 2025 | 7 | 0.230 |
Why?
|
| Surface-Active Agents | 2 | 2021 | 7 | 0.220 |
Why?
|
| DNA Methylation | 2 | 2017 | 144 | 0.220 |
Why?
|
| Animals | 15 | 2025 | 8199 | 0.220 |
Why?
|
| Lung | 5 | 2004 | 263 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 1050 | 0.210 |
Why?
|
| Multiple Sclerosis | 1 | 2025 | 62 | 0.210 |
Why?
|
| Doxorubicin | 1 | 2024 | 76 | 0.200 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 5 | 1998 | 7 | 0.200 |
Why?
|
| Eicosanoids | 2 | 2021 | 9 | 0.200 |
Why?
|
| Acute Lung Injury | 2 | 2015 | 36 | 0.190 |
Why?
|
| Graphite | 1 | 2022 | 5 | 0.190 |
Why?
|
| Energy Intake | 1 | 2023 | 122 | 0.190 |
Why?
|
| Phospholipases A2 | 10 | 2005 | 25 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2003 | 96 | 0.190 |
Why?
|
| Glioblastoma | 1 | 2024 | 159 | 0.190 |
Why?
|
| Diglycerides | 2 | 1998 | 3 | 0.180 |
Why?
|
| Organ Specificity | 2 | 2018 | 80 | 0.180 |
Why?
|
| Indians, North American | 1 | 2021 | 75 | 0.170 |
Why?
|
| Group X Phospholipases A2 | 1 | 2021 | 1 | 0.170 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2021 | 3 | 0.170 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 117 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2007 | 215 | 0.160 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 36 | 0.160 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 108 | 0.160 |
Why?
|
| alpha-Linolenic Acid | 2 | 2017 | 12 | 0.160 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 52 | 0.160 |
Why?
|
| Soybean Oil | 1 | 2020 | 9 | 0.160 |
Why?
|
| Sputum | 3 | 2021 | 17 | 0.160 |
Why?
|
| Metabolomics | 1 | 2020 | 63 | 0.160 |
Why?
|
| Flow Cytometry | 6 | 2016 | 184 | 0.150 |
Why?
|
| Respiratory Burst | 2 | 2016 | 5 | 0.150 |
Why?
|
| Group II Phospholipases A2 | 4 | 2024 | 5 | 0.150 |
Why?
|
| Epithelial Cells | 1 | 2000 | 132 | 0.150 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 155 | 0.150 |
Why?
|
| Enzyme Activation | 4 | 2009 | 138 | 0.150 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2009 | 28 | 0.140 |
Why?
|
| Phosphatidylcholines | 3 | 2011 | 29 | 0.140 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 24 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 140 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2017 | 73 | 0.130 |
Why?
|
| Neurons | 1 | 2020 | 486 | 0.120 |
Why?
|
| Lysophospholipids | 3 | 2005 | 26 | 0.120 |
Why?
|
| Exercise | 1 | 2021 | 603 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 24 | 0.120 |
Why?
|
| Liver | 2 | 2015 | 492 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2015 | 34 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 109 | 0.110 |
Why?
|
| Wasting Syndrome | 1 | 2015 | 14 | 0.110 |
Why?
|
| Physical Conditioning, Animal | 1 | 2015 | 35 | 0.110 |
Why?
|
| Brain | 1 | 2020 | 965 | 0.100 |
Why?
|
| Cytosol | 5 | 2005 | 23 | 0.100 |
Why?
|
| Genotype | 3 | 2020 | 702 | 0.100 |
Why?
|
| Exercise Therapy | 1 | 2015 | 250 | 0.090 |
Why?
|
| Bronchi | 2 | 2004 | 33 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2012 | 57 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 478 | 0.090 |
Why?
|
| Triglycerides | 2 | 2008 | 235 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2011 | 4 | 0.090 |
Why?
|
| Cattle | 1 | 2011 | 116 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 489 | 0.090 |
Why?
|
| Sheep | 1 | 2011 | 194 | 0.090 |
Why?
|
| Adult | 7 | 2024 | 9259 | 0.080 |
Why?
|
| Cytokines | 2 | 2024 | 237 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 520 | 0.080 |
Why?
|
| Biological Transport | 2 | 2020 | 75 | 0.080 |
Why?
|
| Fatty Acids | 3 | 2009 | 100 | 0.080 |
Why?
|
| Oxygen | 3 | 1986 | 138 | 0.080 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2009 | 6 | 0.070 |
Why?
|
| Interleukin-5 | 1 | 2009 | 7 | 0.070 |
Why?
|
| Acyltransferases | 1 | 2009 | 18 | 0.070 |
Why?
|
| Fish Oils | 1 | 2009 | 38 | 0.070 |
Why?
|
| Caspases | 1 | 2009 | 41 | 0.070 |
Why?
|
| Linseed Oil | 1 | 2008 | 2 | 0.070 |
Why?
|
| Calgranulin A | 1 | 2007 | 2 | 0.070 |
Why?
|
| Echium | 1 | 2008 | 11 | 0.070 |
Why?
|
| Calgranulin B | 1 | 2007 | 3 | 0.070 |
Why?
|
| S100 Proteins | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cystic Fibrosis | 2 | 2007 | 25 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 2020 | 839 | 0.070 |
Why?
|
| Male | 7 | 2024 | 19441 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2007 | 50 | 0.070 |
Why?
|
| Granulocytes | 1 | 2007 | 11 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 11 | 0.070 |
Why?
|
| HMGB1 Protein | 1 | 2007 | 11 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 33 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2008 | 727 | 0.060 |
Why?
|
| Endotoxins | 1 | 2007 | 37 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2007 | 46 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 26 | 0.060 |
Why?
|
| COS Cells | 3 | 2004 | 33 | 0.060 |
Why?
|
| Cholesterol | 1 | 2008 | 262 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 146 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 413 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2007 | 146 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2005 | 48 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2005 | 36 | 0.060 |
Why?
|
| Female | 6 | 2024 | 19945 | 0.060 |
Why?
|
| Trachea | 1 | 2005 | 53 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 246 | 0.060 |
Why?
|
| Apoptosis | 1 | 2007 | 375 | 0.060 |
Why?
|
| Mast Cells | 2 | 1995 | 13 | 0.060 |
Why?
|
| European Continental Ancestry Group | 2 | 2020 | 1076 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 152 | 0.050 |
Why?
|
| Allergens | 1 | 2004 | 14 | 0.050 |
Why?
|
| Middle Aged | 4 | 2024 | 11851 | 0.050 |
Why?
|
| Mucus | 1 | 2004 | 4 | 0.050 |
Why?
|
| Cell Line | 2 | 2007 | 454 | 0.050 |
Why?
|
| Respiratory Mucosa | 1 | 2004 | 12 | 0.050 |
Why?
|
| Mucins | 1 | 2004 | 16 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2024 | 60 | 0.050 |
Why?
|
| Kinetics | 2 | 2009 | 250 | 0.050 |
Why?
|
| Young Adult | 2 | 2021 | 2649 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2007 | 499 | 0.050 |
Why?
|
| Aged | 3 | 2024 | 10263 | 0.050 |
Why?
|
| Proteomics | 1 | 2024 | 97 | 0.050 |
Why?
|
| Vegetables | 1 | 2023 | 39 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2003 | 7 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2000 | 80 | 0.050 |
Why?
|
| Fruit | 1 | 2023 | 51 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2003 | 19 | 0.050 |
Why?
|
| Saliva | 1 | 2003 | 39 | 0.050 |
Why?
|
| Transfection | 2 | 2000 | 204 | 0.050 |
Why?
|
| Electroplating | 1 | 2022 | 2 | 0.050 |
Why?
|
| Durapatite | 1 | 2022 | 9 | 0.050 |
Why?
|
| Porosity | 1 | 2022 | 39 | 0.050 |
Why?
|
| Phosphorylation | 3 | 1998 | 250 | 0.050 |
Why?
|
| Bone Regeneration | 1 | 2022 | 33 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2022 | 79 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 144 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 729 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2008 | 820 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 1998 | 22 | 0.040 |
Why?
|
| Heredity | 1 | 2021 | 12 | 0.040 |
Why?
|
| Bronchoconstriction | 1 | 2021 | 3 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 853 | 0.040 |
Why?
|
| Osmotic Pressure | 1 | 2021 | 16 | 0.040 |
Why?
|
| Adolescent | 3 | 2021 | 3519 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 40 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2000 | 34 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2020 | 19 | 0.040 |
Why?
|
| Pericytes | 1 | 2020 | 32 | 0.040 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2020 | 14 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 74 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2000 | 67 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 61 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 99 | 0.040 |
Why?
|
| African Americans | 2 | 2017 | 1335 | 0.040 |
Why?
|
| Surface Tension | 3 | 2005 | 6 | 0.040 |
Why?
|
| Models, Immunological | 1 | 1999 | 8 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2022 | 431 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 757 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2020 | 193 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1479 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 1998 | 6 | 0.040 |
Why?
|
| Lipids | 1 | 2020 | 253 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 565 | 0.040 |
Why?
|
| Swine | 3 | 2005 | 228 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 637 | 0.040 |
Why?
|
| Lung Injury | 1 | 1999 | 67 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2020 | 255 | 0.040 |
Why?
|
| Blotting, Western | 1 | 1998 | 299 | 0.030 |
Why?
|
| CpG Islands | 1 | 2017 | 44 | 0.030 |
Why?
|
| Cell Separation | 1 | 1998 | 89 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1997 | 34 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 101 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 132 | 0.030 |
Why?
|
| Biological Products | 1 | 1998 | 79 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2022 | 695 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2016 | 74 | 0.030 |
Why?
|
| Phagocytes | 1 | 1995 | 5 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1840 | 0.030 |
Why?
|
| Blood Cells | 1 | 1995 | 9 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2015 | 28 | 0.030 |
Why?
|
| Superoxides | 1 | 1995 | 24 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 274 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2007 | 131 | 0.030 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2015 | 9 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 23 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 20 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 34 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 38 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2015 | 63 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 2316 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 792 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 121 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 74 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 181 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 250 | 0.030 |
Why?
|
| Hydrogen Peroxide | 2 | 1985 | 85 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2014 | 128 | 0.020 |
Why?
|
| United States | 1 | 2021 | 4072 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 332 | 0.020 |
Why?
|
| Influenza A virus | 2 | 1990 | 22 | 0.020 |
Why?
|
| Fluoresceins | 3 | 1986 | 9 | 0.020 |
Why?
|
| Monocytes | 2 | 2007 | 141 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 1990 | 20 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1083 | 0.020 |
Why?
|
| Acute Disease | 2 | 2007 | 253 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 2205 | 0.020 |
Why?
|
| Bone Resorption | 1 | 1989 | 11 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1989 | 38 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 2009 | 3 | 0.020 |
Why?
|
| Osteoclasts | 1 | 1989 | 25 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 1990 | 93 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 55 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1989 | 91 | 0.020 |
Why?
|
| RNA | 1 | 2009 | 94 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 1985 | 76 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 150 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 12 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2007 | 22 | 0.020 |
Why?
|
| Calcium | 1 | 1989 | 339 | 0.020 |
Why?
|
| Necrosis | 1 | 2007 | 54 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 112 | 0.020 |
Why?
|
| Endocytosis | 1 | 1986 | 9 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 116 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1158 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3934 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2007 | 224 | 0.020 |
Why?
|
| Microsomes | 1 | 2005 | 12 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2005 | 35 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2005 | 23 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 37 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 43 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 32 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 33 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 43 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 51 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 854 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1985 | 17 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1985 | 6 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 174 | 0.010 |
Why?
|
| Influenza, Human | 1 | 1986 | 121 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1984 | 19 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2004 | 9 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2004 | 15 | 0.010 |
Why?
|
| Sepsis | 1 | 1986 | 164 | 0.010 |
Why?
|
| Mucin-5B | 1 | 2004 | 1 | 0.010 |
Why?
|
| Bronchitis | 1 | 2004 | 2 | 0.010 |
Why?
|
| Mucin 5AC | 1 | 2004 | 2 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 264 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2004 | 34 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 74 | 0.010 |
Why?
|
| Eosinophil Granule Proteins | 1 | 2003 | 2 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 223 | 0.010 |
Why?
|
| Peroxidase | 2 | 1995 | 27 | 0.010 |
Why?
|
| Snake Venoms | 1 | 1998 | 2 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1998 | 7 | 0.010 |
Why?
|
| Mammals | 1 | 1998 | 14 | 0.010 |
Why?
|
| Pancreas | 1 | 1998 | 107 | 0.010 |
Why?
|
| Child | 1 | 2004 | 2435 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1997 | 11 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1997 | 2 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1997 | 6 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1997 | 93 | 0.010 |
Why?
|
| Mice | 2 | 1994 | 2571 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1995 | 12 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1995 | 2 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 1995 | 3 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 22 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1995 | 59 | 0.010 |
Why?
|
| Cell Movement | 1 | 1995 | 167 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1994 | 7 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 1994 | 4 | 0.010 |
Why?
|
| Macrophages | 1 | 1995 | 207 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1990 | 20 | 0.000 |
Why?
|
| Actins | 1 | 1990 | 54 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1990 | 63 | 0.000 |
Why?
|
| Microfilament Proteins | 1 | 1990 | 37 | 0.000 |
Why?
|
| Acridine Orange | 1 | 1989 | 1 | 0.000 |
Why?
|
| Calcium Radioisotopes | 1 | 1989 | 1 | 0.000 |
Why?
|
| Calcitonin | 1 | 1989 | 4 | 0.000 |
Why?
|
| Acids | 1 | 1989 | 4 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1989 | 14 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1989 | 46 | 0.000 |
Why?
|
| Pinocytosis | 1 | 1986 | 2 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1986 | 15 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1986 | 43 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1986 | 7 | 0.000 |
Why?
|
| Permeability | 1 | 1986 | 11 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1986 | 43 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1986 | 28 | 0.000 |
Why?
|
| Free Radicals | 1 | 1986 | 10 | 0.000 |
Why?
|
| Blood Physiological Phenomena | 1 | 1984 | 2 | 0.000 |
Why?
|
| Opsonin Proteins | 1 | 1984 | 6 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1984 | 55 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1984 | 129 | 0.000 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1983 | 6 | 0.000 |
Why?
|